These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 3310020)

  • 21. A multicenter study of nabumetone and diclofenac SR in patients with osteoarthritis.
    Bellamy N; Bensen WG; Beaulieu A; Siminovitch KA; Kraag GR; Lussier A; Ahmad S; Khanna VN; Davis P; Bell MJ
    J Rheumatol; 1995 May; 22(5):915-20. PubMed ID: 8587082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of the effectiveness and safety of two non-steroidal anti-inflammatory agents, nabumetone and naproxen in rheumatoid arthritis.
    Fostiropoulos G; Croydon EA
    J Int Med Res; 1982; 10(4):204-8. PubMed ID: 6749576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.
    Lister BJ; Poland M; DeLapp RE
    Am J Med; 1993 Aug; 95(2A):2S-9S. PubMed ID: 8356999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nabumetone in the treatment of skin and soft tissue injury.
    Jenner PN
    Am J Med; 1987 Oct; 83(4B):101-6. PubMed ID: 3318420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nabumetone: a double-blind study in osteoarthrosis.
    Gillgrass J; Grahame R
    Pharmatherapeutica; 1984; 3(9):592-4. PubMed ID: 6374679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly.
    Morgan GJ; Poland M; DeLapp RE
    Am J Med; 1993 Aug; 95(2A):19S-27S. PubMed ID: 8356998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analgesic activity of nabumetone versus naproxen in acute exacerbation of osteoarthritis. A short term study.
    Cazzola M; Montrone F; Azzolini V; Vaiani G; Caruso I
    Drugs; 1990; 40 Suppl 5():78-9. PubMed ID: 2081501
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of the safety and efficacy of nabumetone and aspirin in the treatment of osteoarthritis in adults.
    Appelrouth DJ; Baim S; Chang RW; Cohen MH; Englund DW; Germain BF; Hartman SS; Jaffer A; Mullen BJ; Smith FE
    Am J Med; 1987 Oct; 83(4B):78-81. PubMed ID: 3318434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoscopic studies of nabumetone in patients with rheumatoid arthritis. A comparative endoscopic and histologic evaluation.
    Greb WH; von Schrader HW; Cerlek S; Dominis M; Hauptmann E; Zenić N
    Am J Med; 1987 Oct; 83(4B):19-24. PubMed ID: 3318423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized double-blind study of nabumetone and piroxicam in the treatment of osteoarthritis in Dutch general practice: efficacy and tolerability.
    De Bock GH; Hermans J; Mulder JD
    Pharm World Sci; 1993 Jun; 15(3):132-8. PubMed ID: 8348110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis.
    Kivitz A; Eisen G; Zhao WW; Bevirt T; Recker DP
    J Fam Pract; 2002 Jun; 51(6):530-7. PubMed ID: 12100776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerance of naproxen versus pirprofen in the treatment of patients with osteoarthritis.
    Boussina I; Vischer TL
    Pharmatherapeutica; 1987; 5(1):16-20. PubMed ID: 3602020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with active osteoarthritis of the knee.
    Schnitzer TJ; Ballard IM; Constantine G; McDonald P
    Clin Ther; 1995; 17(4):602-12. PubMed ID: 8565024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etodolac (Lodine) in the treatment of osteoarthritis: recent studies.
    Schnitzer TJ; Constantine G
    J Rheumatol Suppl; 1997 Feb; 47():23-31. PubMed ID: 9035017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and improved safety--a new anti-arthritic agent.
    Irani M
    Eur J Rheumatol Inflamm; 1991; 11(3):43-9. PubMed ID: 1365480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d of nabumetone in the treatment of patients with osteoarthritis of the knee.
    Makarowski W; Weaver A; Rubin B; Caldwell J; McMahon FG; Noveck RJ; Lee D; Offenberg H; Sack M; Sikes D; Trapp R; Rush S; Kuss M; Ganju J; Bocanegra TS; Ratliff JM
    Clin Ther; 1996; 18(1):114-24. PubMed ID: 8851458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of naproxen and nabumetone on serum cholesterol levels in patients with osteoarthritis.
    Young D; Peterson C; Basch C; Halladay SC
    Clin Ther; 1995; 17(2):231-40. PubMed ID: 7614523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.
    Eversmeyer W; Poland M; DeLapp RE; Jensen CP
    Am J Med; 1993 Aug; 95(2A):10S-18S. PubMed ID: 8356997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nabumetone compared with indomethacin in the treatment of osteoarthritis in general practice.
    Carle WK; Wade AG; Kill DC; Poland M
    J Rheumatol Suppl; 1992 Nov; 36():58-62. PubMed ID: 1474536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nabumetone: a single-center three-week comparison with placebo in the treatment of rheumatoid arthritis.
    Turner RA; Brindley DA; Mitchell FN
    Am J Med; 1987 Oct; 83(4B):36-9. PubMed ID: 3318426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.